Significant differences in expression of these three biomarkers between tumor tissues and normal were observed in the TCGA-LIHC dataset and the FAHMSZU cohort, indicating that YWHAB, PPAT, NOL10 were overexpressed, especially in patients with advanced pathological T grade and stage. This evidence concerns the gene NOL10 and neoplasm.